spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Stratophase appoints Remy Martin as Business Development Manager

Stratophase

Stratophase has today announced the appointment of Remy Martin as Business Development Manager

Romsey, UK; 9 August 2017. Stratophase, the UK-based biopharmaceutical services and technology company, has today announced the appointment of Remy Martin as Business Development Manager.

Remy’s main responsibility will be to build and manage the company’s growing portfolio of Ranger® bioprocessing contract services. He will focus primarily on the European market and report to Stratophase CEO Simon Saxby.

Remy brings to Stratophase a wealth of experience and knowledge of upstream process development, process control and sensor technologies.

He joins the company from the University of Bristol, where he was employed as a Post-Doctoral Research Associate. Prior to that, Remy worked as a Bioreactor Specialist at Applikon Biotechnology UK, providing bespoke bioreactor control solutions.

Remy has a PhD in Biochemistry from the University of Bristol and an MBiol in Molecular & Cellular Biology from the University of Bath.

Commenting on Remy Martin’s appointment, CEO Simon Saxby said: “Remy’s enthusiasm for, and experience in, bioreactor control fit perfectly with the on-going development of Ranger© adaptive control contract services and their take-up by the global biopharma industry”.
phone +44 (0)1794 511226
email enquiries@stratophase.com
web https://www.stratophase.com
email Unit 10a, The Quadrangle, Premier Way , Romsey, Hampshire, SO51 9DL
 
Print this page
Send to a friend
   
spacer
News and Press Releases

MRC Technology monetises royalties on cancer drug Keytruda (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital


More info >>


White Papers

Changing Structural Landscape for Comparator Drug Supply

ADAllen Pharma

TransCelerate Biopharma is focused on advancing innovation in R&D, identifying and solving common R&D challenges and further improving patient safety, with the goal of delivering more high quality medicines to patients. In 2013, they announced its Clinical Trial Comparator Network initiative to show a mutual commitment to offer secure and rapid supply of comparator drug products. The aim of this article is to unpack the section on 'Comparator Drugs' and analyse the rationale for attempting to achieve their objectives.
More info >>

Industry Events

8th Clinical Quality Oversight Forum 2017

11-13 October 2017, Sheraton Philadelphia Downtown Hotel, Philadelphia, PA

ExL’s Clinical Quality Oversight Forum continues to live up to its reputation as an elite gathering of senior-level executives.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement